E-ISSN 2534-9821
 

Case Report 


Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy

Faridha Ilyas.

Abstract
Leprosy is a chronic and progressive granulomatous disease that primarily affects the skin and peripheral nervous system caused by Mycobacterium leprae. If left unrecognized, infection can cause permanent nerve damage and disability. The mid-borderline type is the most unstable type, where clinical presentation depends on the patient's immune response and may result in a broad spectrum of symptoms. ROM (rifampicin, ofloxacin, minocycline) is second-line therapy for leprosy recommended by WHO for patients who have contraindications or reject MDT administration.
A case of a 49-year-old male patient was reported with ulcer on the right hand, peeled skin on both hands, legs, accompanied with erythematous nodules and plaque, and hyperpigmented macules almost all over body. Skin all over body were painful and followed with fever. Clinical manifestation is mimicking borderline lepromatous and severe leprosy reaction, but histopathology result support Borderline borderline leprosy. The ptient was treated with Rifampisin, Ofloxacin, Minoksiklin (ROM) and Prednison, which resulted in significant clinical improvement

Key words: Borderline borderline, Leprosy, ROM


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Faridha Ilyas
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ilyas F, . Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep. 2019; 3(5): 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


Web Style

Ilyas F, . Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. http://www.mdpub.net/?mno=34368 [Access: August 11, 2020]. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


AMA (American Medical Association) Style

Ilyas F, . Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep. 2019; 3(5): 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features



Vancouver/ICMJE Style

Ilyas F, . Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep. (2019), [cited August 11, 2020]; 3(5): 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features



Harvard Style

Ilyas, F. & (2019) Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep, 3 (5), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features



Turabian Style

Ilyas, Faridha, and . 2019. Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. International Journal of Medical Reviews and Case Reports, 3 (5), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features



Chicago Style

Ilyas, Faridha, and . "Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy." International Journal of Medical Reviews and Case Reports 3 (2019), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features



MLA (The Modern Language Association) Style

Ilyas, Faridha, and . "Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy." International Journal of Medical Reviews and Case Reports 3.5 (2019), 286-289. Print. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features



APA (American Psychological Association) Style

Ilyas, F. & (2019) Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. International Journal of Medical Reviews and Case Reports, 3 (5), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features